KRTX 329.83 (+0%)
US48576A1007BiotechnologyBiotechnology

Karuna Therapeutics (KRTX) Stock Highlights

329.83 | +0%
2024-12-21 01:00:55
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.

Statistics

Range Today
329.83 329.83
Volume Today 0
Range 1 Year
158.38 329.99
Volume 1 Year 123.93M
Range 3 Year
92.26 329.99
Volume 3 Year 254.95M
Range 10 Year
11.24 329.99
Volume 10 Year 382.5M

Highlights

Market Capitalization 12.6B (large)
Floating Shares 36.27M
Current Price 329.83
Price To Earnings -28.09
Price To Revenue 17.33K
Price To Book 10.01
Earnings Per Share -11.74
Payout Ratio 0%

Performance

Latest 0%
1 Month +3.8%
3 Months +50.49%
6 Months +82.88%
1 Year +57.14%
3 Years +177.28%
5 Years +1682.86%
10 Years +1682.86%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.